This page was machine-translated from Korean. For medical decisions, please confirm with the hospital.View in Korean

Conditions treated

  • Multiple myeloma
  • Lymphoma
  • Leukemia
  • Hematopoietic stem cell transplantation

Provides care based on specialized expertise in cell therapy and multiple myeloma, with thorough consultations that have established trust.

Hospital information

Hospital
Seoul National University Hospital
Address
101 Daehak-ro, Jongno-gu, SeoulOpen in Google Maps
Appointments
1588-5700

Patient rating

Based on 1 patient ratings

  • Medical skill4.0
  • Expertise4.0
  • Explanation4.0
  • Kindness4.0
  • Sincerity4.0

Education

  • 2015–2019 Doctor of Medicine, Seoul National University College of Medicine
  • 2013–2015 Master of Medicine, Kyung Hee University College of Medicine
  • 2004–2010 Bachelor of Medicine, Kyung Hee University College of Medicine

Career

  • September 2023–present Associate Professor, Department of Internal Medicine, Seoul National University College of Medicine
  • June 2019–August 2023 Clinical Assistant Professor and Assistant Professor, Division of Hematology and Medical Oncology, Seoul National University Hospital
  • March 2017–May 2019 Clinical Assistant Professor, Division of Hematology and Medical Oncology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center
  • July 2016–August 2016 Visiting Scientist at Ontario Institute for Cancer Research (OICR)
  • March 2015–February 2017 Clinical Fellow, Division of Hematology and Medical Oncology, Seoul National University Hospital
  • Title: Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma.
  • Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY
  • Publication date: 2021-2
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/33995990/
  • Title: Gaucher disease type 1: unexpected diagnosis in a 75-year old patient presenting with splenomegaly.
  • Journal: CURRENT PROBLEMS IN CANCER
  • Publication date: 2021-2
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/33583590/
  • Title: Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin.
  • Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY
  • Publication date: 2021-2
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/34987742/
  • Title: Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
  • Journal: SCIENTIFIC REPORTS
  • Publication date: 2021-1
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/34773060/
  • Title: Successful management of severe allergic reactions to platelet transfusion with omalizumab a case report.
  • Journal: MEDICINE
  • Publication date: 2021-1
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/34871268/

Academic societies & awards

  • Current: 2024–present Asia Myeloma Network / Member
  • Current: 2022–present European Hematology Association / Member
  • Current: 2021–present International Workshop on CLL (iwCLL) Global Partnerships Subcommittee / Regional Lead
  • Current: 2018–present American Society of Hematology / International Member
  • Current: 2015–present Korean Society of Hematology / Full Member
  • Current: 2015–present Korean Society for Blood and Marrow Transplantation / Full Member

Frequently asked questions

What conditions does Byun Ja-min treat?
Byun Ja-min treats Multiple myeloma, Lymphoma, Leukemia and Hematopoietic stem cell transplantation.
Where does Byun Ja-min see patients?
Byun Ja-min sees patients in Hematology and Oncology at Seoul National University Hospital. 101 Daehak-ro, Jongno-gu, Seoul
How do I book an appointment with Byun Ja-min?
Book through the hospital website or by phone (1588-5700). Large university hospitals usually need a referral letter from a local clinic for National Health Insurance to apply.